A liquid orally administrable pharmaceutical compositions containing 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl } -methyl) -2-thiophenecarboxamide

The present invention relates to liquid pharmaceutical compositions comprising 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5 yl} -methyl) -2-thiophenecarboxamide contained, their preparation and their use for the prophylaxis and / or treatment of disorders.